Dr. Howard I. Scher Honored with Richard D. Williams, MD Prostate Cancer Research Excellence Award

Apr 25

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

The PCCTC at SES AUA 2025: Phase 1 Trial of Mevrometostat (PF-06821497), a Potent and Selective Inhibitor of EZH2, in CRPC